U.S. Continues Sales Of Actos Despite Multi-Nation Ban

Type 2 diabetes drug Actos continues to be sold in the U.S., despite a number of other countries removing it from the market, and a recent settlement agreement under which $2.4 billion will be paid to patients who claim to have experienced side effects from the drug. Lawsuits are pending involving nearly 9,000 patients who allege that they were not adequately warned about the drug’s potential to cause bladder cancer in long-term users, a Louisiana Actos lawyer notes.

If you or a loved one suffered complications after taking Actos, contact Attorney Group for Louisiana today to discuss your options in a free, confidential, no-obligation consultation. We can answer your questions, and if you decide to pursue a claim for compensation, we can connect you with an affiliated Invokana lawsuit attorney who can assist you throughout the legal process.

The time you have to pursue a claim is limited. Contact us for more information.Get Help Now.

Germany And France Are Among The Countries Who Have Halted Actos Sales

At the heart of the litigation involving Takeda Pharmaceuticals, the Japanese pharmaceutical company that manufactures and markets the diabetes drug Actos, is an allegation of negligence made by the plaintiffs. The Cook County Record reports that Takeda allegedly failed to properly warn Actos users about the drug’s link to bladder cancer, despite allegedly having this information prior to the drug hitting the market 16 years ago. Although Actos is still available as a Type 2 diabetes treatment in the U.S., countries such as Germany and France are among those that have halted its sales.

Patients who took Actos and weren’t properly warned about the cancer risk may soon find comfort in the form of a massive payout from Takeda. It is estimated that the company will pay $2.4 billion to plaintiffs if 97 percent of them have agreed to a settlement. If only 95 percent agree, than the company will pay $2.37 billion, the website reported.

Injured Patients May Be Entitled to Compensation

Drug manufacturers have a duty to ensure their products are accompanied by full and accurate instructions and warnings to guide prescribing doctors and other health care providers in making treatment decisions. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

Patients who have been injured by Actos may be entitled to compensation for damages, including:

  • Medical expenses
  • Pain, suffering, and mental anguish
  • Loss of income or ability to work

If a patient dies from complications after taking Actos, his or her family members may be able to pursue claims for their loved one’s wrongful death. Compensation may include:

  • Pain, suffering, and mental anguish from the loss of a loved one
  • Loss of financial support of a loved one
  • Funeral expenses

Affected patients are encouraged to speak with an Actos lawsuit attorney to learn more about their rights and remedies.

Contact Us For More Information

If you or a loved one took Invokana and suffered complications, contact Attorney Group for Louisiana for more information. You can fill out the form on this page, call us at the number listed at the top of the page, or email us at info@attorneygroup.com.

When you contact us, an attorney will follow up with you to speak with you about your case or answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim for an injury. If you think you have a case, you should not delay taking action.

See our Frequently Asked Questions page for more information, and contact Attorney Group for Louisiana today.

Comments